Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
People with subjective memory concerns (no diagnosis):
- You score between 26 and 30 on a standard memory and thinking test (MMSE or MoCA).
- You do not have a diagnosis of cognitive impairment or dementia.
- You or a family member have noticed problems with your memory.
- You can speak and understand Swedish.
People with mild cognitive impairment:
- You score between 24 and 30 on a standard memory and thinking test (MMSE or MoCA).
- You have measurable problems with memory but do not have a dementia diagnosis.
- A specific marker for Alzheimer's disease has been found in your spinal fluid.
- You can speak and understand Swedish.
People with Alzheimer's disease:
- You score between 18 and 28 on a standard memory and thinking test (MMSE or MoCA).
- You have memory problems along with difficulties in at least one other area, such as language, attention, spatial awareness, or planning.
- You have received a formal diagnosis of probable Alzheimer's disease.
- A specific marker for Alzheimer's disease has been found in your spinal fluid.
- You can speak and understand Swedish.
Who may not be able to join:
- People with a current alcohol or drug abuse problem.
- People with an unstable or serious physical illness or organ failure.
- People who are not willing to undergo spinal fluid testing, blood tests, brain scans, brainwave recordings, or thinking and memory assessments.
- People who have claustrophobia (fear of enclosed spaces) that would prevent them from having a brain scan.
- People who have a metal implant in their body that could interfere with brain scanning equipment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +46709966186
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Brain connectivity can predict the development of Alzheimer's disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.